Table 3 Value distribution of serum CA125 in ovariectomized, non-recurrent, postoperative patients of gynecological malignant tumor
Type | Pathology staging | Total | CA125 level(U/ml) | |||||
|---|---|---|---|---|---|---|---|---|
I | II | III | IV | Range | Median | X ± S | ||
Fallopian tube cancer | 3 | 7 | 17 | 6 | 33(5.5) | 4.1 ~ 12.0 | 7.4 | 8.1 ± 2.4 |
Endometrial cancer | 55 | 88 | 21 | 3 | 167(27.7) | 3.1 ~ 15.1 | 7.0 | 7.3 ± 2.8 |
Cervical cancer | 152 | 200 | 34 | 17 | 403(66.8) | 3.5 ~ 20.8 | 6.6 | 6.7 ± 2.2 |
Total | 210 | 295 | 72 | 26 | 603(100) | 4.1 ~ 20.8 | 7.2 | 6.8 ± 2.1 |